On November 4, 2024, Director Abhijit Talwalkar of iRhythm Technologies Inc (IRTC, Financial) purchased 6,664 shares of the company, as reported in a recent SEC Filing. Following this transaction, the insider now owns a total of 18,941 shares of iRhythm Technologies Inc.
iRhythm Technologies Inc is a healthcare company that specializes in developing and marketing cardiac monitoring solutions. The company's technology aids in the detection and analysis of heart rhythm disorders.
The transaction occurred with the shares priced at $75.16 each, placing the total value of the purchase at approximately $500,586. The company's market cap following the purchase is approximately $2.75 billion.
Over the past year, Abhijit Talwalkar has bought a total of 6,664 shares and has not sold any shares. The insider transaction history for iRhythm Technologies Inc shows a trend with 2 insider buys and 18 insider sells over the past year.
According to the GF Value, the stock is currently valued at $142.86, suggesting that it is possibly undervalued. The price-to-GF-Value ratio stands at 0.53, indicating the stock might be a possible value trap and investors should think twice before investing.
The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted by GuruFocus based on the company’s past performance and estimated future business outcomes.
This insider buying activity could be a signal to investors about the potential undervaluation of iRhythm Technologies Inc based on internal assessments by the company's directors.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
